Mutant-selection window (MSW) hypothesis in antimicrobial resistance implies a range 18 for antimicrobial concentration that promotes selection of single-step resistant mutants. 19
Introduction

35
The gain of resistance to antimicrobials is indeed one of the most challenging threats to 36 public health. An effective approach to contain antimicrobial resistance (AMR) is multi-37 layered, employing knowledge of the mechanisms for gain of resistance, ecological 38 dynamics of bacterial species and eventually treatment regimens and strategies 1 . 39
Since their first medical use, antimicrobials have been administered at a 40 minimum dosage sufficient to inhibit bacterial growth while keeping hazards minimal. 41
This concentration, termed as minimum inhibitory concentration (MIC) 2,3 , measures 42 susceptibility of bacteria to drugs and is the basis of clinical protocols that compare 43 effectiveness of antimicrobials 4 . The emergence of AMR requires that at least two sub-44 populations of bacterial species exist, with distinct MICs. The dosage response of 45 bacterial growth to antimicrobials thus defines a concentration window that is above the 46 MIC of wild-type and below the MIC of resistant mutants, i.e., mutant-selection window 47 (MSW) hypothesis 5-7 . The upper limit of this window (i.e., MIC of resistant mutants) is 48 termed as mutant-prevention concentration (MPC) 7 . An effective treatment strategy for 49 AMR sets drug dosage above MPC to inhibit the selection of resistant mutant 6 . 50
Setting the upper and lower limits of MSW is critically important. Obviously, MPC 51 should be high enough to prevent emergence of AMR, but should be the lowest 52 efficacious concentration to minimize side effects. The lower limit, on the other hand, is 53 the minimum selective concentration (MSC) 8 below which resistance and efficacy are 54 hardly achieved and can be regarded as a safety level for antimicrobial concentration in 55 natural environments 9 . MSC was traditionally assumed to be the MIC of WT strains, but 56 of enzymes targeted by antimicrobials such as dihydrofolate reductase (DHFR) in folate 79 pathway 14 or competitive inhibition in the case of TEM-1 beta lactamase 15,17 . 80 Given such predictive models of AMR and the resulting fitness landscape from 81 exhaustive mutagenesis experiments, an interesting question is whether these models 82
can be employed to investigate the limits of MSW in AMR. If proved successful, this 83 "bottom-up" approach would result in a predictive model for selective window that will 84 eventually aid in optimizing dosage regimens. This is the major goal of the current 85 work. We will start with a general summary of the predictive model of AR in TEM-1 beta 86 lactamase which relates fitness to the rate of peptidoglycan synthesis and cell wall 87 formation. This rate in turn depends on variety of molecular and cellular factors from 88 permeability of antimicrobials to the catalytic efficiency, k cat /K M , of both penicillin binding 89 proteins (PBPs) and TEM-1 beta lactamase 17, 18 . MSW is then derived from the fitness 90 equation and the landscape for selection coefficients of arising AMR is explored. We 91 then employ this method to investigate the lower and upper theoretical limits of selective 92 window in AMR and comment on dependence of this limit to factors such as enzyme 93 kinetics and the fraction of resistant mutants in the population. 94
96
Results 97 98
Fitness model for TEM-1 beta lactamase 99 100
TEM-1 beta lactamase or in general beta lactamases are a family of enzymes that give 101 resistance to beta lactam antibiotics [19] [20] [21] [22] . This group of antibiotics which share the 102 common functional group of beta lactam, inhibits formation of the peptidoglycan cross-103 links in the bacterial cell wall. The specific mode of action of beta lactam antibiotics is the competitive binding with DD-transpeptidases, which are collectively known as 105 penicillin binding proteins (PBP) 23 . PBPs are involved in the final step of peptidoglycan 106 synthesis and thus cell wall biogenesis 24 . Resistance to beta lactam antibiotics, by beta 107 lactamases, is achieved through attacking the beta lactam ring of these antibiotics. 108
Therefore, bacterial growth under the concentration of beta lactam antibiotics is 109
proportional to the activity of PBPs. 110 Figure 1 depicts the mechanistic model for the function of TEM-1 beta 111 lactamases within the cell. As in Figure 1A , beta lactam antibiotics diffuse through 112 membrane barrier and once in periplasm, they face either hydrolyses by TEM-1 beta 113 lactamases or diffusion towards their target, PBPs. The fitness of a bacterial cell, i.e., 114 growth rate, is modeled by the PBPs activity, v PBP ( Figure 1B -C) which is expressed as: 115
Here, C and [ßlac] p are the periplasmic concentration of peptidyglycan and beta lactam 117 antibiotic, concentration of active PBPs in the periplasm and, dissociation constant of beta lactam 119 antibiotic from PBPs. As assumed in previous works 17, 18 , the rate of beta lactam 120 hydrolysis is equal to that of diffusion across periplasm. Hence, one can find the 121 following expression for the concentration of beta lactam antibiotic in the periplasm: 122 
We define the lower and upper limits of MSW, namely MSC and MPC, as the two roots 131 of Eq. 4. We then systematically explore MSC, MPC and MSW as a function of 132 biophysical properties and population genetic parameters. For these analyses, we used 133 three datasets. First, a set of k cat and K M of 4997 TEM-1 mutants against ampicillin that 134 was obtained by fitting the described fitness model to the relative fitness data from a 135 recent mutational scan 17 . Second, two sets of known kinetic data for TEM-1 variants as 136 tabulated in Table S1 -2 for reactions with ampicillin and cefotaxime. 137
We first considered the dependence of selection coefficient to the antimicrobial 138 concentration. Figure 2 shows the average and standard deviation of s for all 4997 139 TEM-1 mutants against Ampicillin. From the figure, mutants become more deleterious 140
i.e., having larger negative selection coefficients, at higher ampicillin concentrations. 141 Figure 2B shows the same plot with a finer range of s = -0.02 to 0.02. The area depicted 142 in gray shows the nearly neutral range (hereafter called nearly-neutral zone) 143 corresponding to |N eff s|~1, where the effective population size, N eff , is assumed to be 144 selection coefficient of beneficial mutations has a quadratic dependence on the 147 antimicrobial concentration and crosses the nearly-neutral zone at a lower and a higher 148 concentration of antibiotic. The lower and higher concentrations correspond to the 149 minimum selective concentration, MSC and, mutant prevention concentration, MPC, 150 respectively (see Methods). 151
We calculated MSC and MPC for TEM-1 beneficial mutations against ampicillin 152
in Figure 3A -B. As shown in Figure 3A , MSC is ~ two-three orders of magnitude lower 153 than MIC of TEM-1 against ampicillin (~1000-4000 µg/ml [25] [26] [27] ). This shows that 154 selection is active at these very low concentrations in line with previous observations for 155 the prevalence of mutant selection at sub-MIC regimes 8, 10, 28, 29 . There is an inverse 156 exponential relationship between MPC and MSC as shown in Figure 3C . Beneficial 157 mutations with higher selective advantages at lower antimicrobial concentrations would 158 indeed require higher antimicrobial concentrations for prevention. The maximum MPC 159 belonged to P27E mutant (~10 6 µg/ml). Notably, mutations in residue 173 that are 160 observed in laboratory evolution of TEM-1 30,31 and in clinical isolates 32 are among 161 beneficial mutations. 162
Next, we looked at the individual s curves for TEM-1 mutants against ampicillin. 163
As shown in Figure 4A , selection coefficients are sigmoidal in antimicrobial 164 concentrations with two interesting features: I) selection coefficients are clustered and 165 non-randomly distributed at different concentrations and II) mutations do not preserve 166 their selective rank at all antimicrobial concentrations. Simply put a high fit mutant to 167 lower concentrations of ampicillin (compared to all other mutants) would not retain the 168 same fitness rank at higher concentrations. Below, we discuss these two features in 169 detail. 170
The clustering of selection coefficients of several mutations implies that s values 171 are non-uniformly distributed. To see the pattern of clustering, we compared the 172 distribution of distances between selection coefficients with that of an equidistance 173 distribution using Kolmogorov-smirnov test. Selection coefficients at all antimicrobial 174 concentrations were significantly non-equidistant (p-value < 10 -16 ). Then, we looked at 175 the optimum number of clusters and the centroids as shown in Figure showing a rich heterogeneity in selective advantage/disadvantage of mutant clusters at 184 different antibiotic concentrations. Interestingly, a sudden overpopulation of mutants 185 (~2/5 of all mutants) in lower more neutral clusters occurs around MIC, shown with a 186 black arrow in Figure 4C . 187
Another interesting feature of Figure 4A is that s-curves cross each other at different 188 antimicrobial concentrations. This implies that the rank of different mutants is not 189 preserved at all antimicrobial concentrations. To illustrate this observation further, we 190 plotted selection coefficients of two mutants, L152C and G251R, in black and gray in Figure 5A . The corresponding values for V max and K M of both mutants are shown 192 accordingly. From the figure, at low antimicrobial concentrations, the mutant with lower 193 half-saturation limit (L152C) has a higher selective advantage despite having ~16% less 194 turnover rate. The more efficient G251R mutant gains a higher fitness once 195 antimicrobial concentration reaches the corresponding half-saturation limit. 196
The lack of rank-preservation at different antibiotic concentrations means that a 197 mutant that confers resistance at one antibiotic concentration would not necessarily do 198 so at a different concentration. This adds another level of impairment for predictability of 199 antimicrobial resistance in addition to stochastic rise and fixation of resistant mutations. 200
To check the rank of mutants at different antimicrobial concentrations systematically, we 201 compared the rank of all TEM-1 mutants at 9 antimicrobial concentrations 1000 to 9000 202 µg/ml to the ranks at 1 µg/ml. As shown in Figure 5B , the original rank is lost at all 203 higher concentrations. In fact, the correlation between the rank of mutants among all 204 concentrations although significant is very weak (R~0.01, p-value<10 -3 ; see Figure S1 -205 2). We also checked the preservation of ranks at ampicillin concentrations below 1000 206 µg/ml. As shown in Figure 5C , the maximum correlation is ~0.35 which decays to ~0.05 207 as the antimicrobial concentration increases. 208
To explore the dependence of MSW to enzyme kinetics, we plotted V max and K M 209 of TEM-1 beneficial mutations. Deleterious and neutral mutations are shown in gray and 210 beneficial mutations in black. From the figure, beneficial mutations have maximized V max 211 and minimized K M leading to maximized V max /K M ratio (see the fitted dashed line to all 212 beneficial mutations in Figure 6A ). We then plotted MSC and MPC versus V max /K M of all 213 beneficial mutants of TEM-1 ( Figure 6B-C) . From the figure, mutants with a higher catalytic efficiency have lower MSC and higher MPC giving rise to an increased MSW. 215
We thus conclude that V max /K M ratio is a strong determinant of MSC and MPC in the 216 case of TEM-1 and ampicillin resistance. 217
To what extend the selection regime and the concentration-dependence of 218 selection coefficient discussed in Figure 2 are common to other beta-lactam 219
antimicrobials? To answer this question, we sought to analyze fitness effects of arising 220 mutations in TEM-1 against cefotaxime. Resistance to cefotaxime is widely reported for 221 TEM-1 and the extended-spectrum beta lactamases (ESBLs). Figure S2 shows the 222 selection coefficient curves for TEM-1 mutants and natural variants where kinetic data 223 for reaction with cefotaxime were available (Table S2 ). Evidently, a major difference 224 with the case of ampicillin is the degree to which mutants are beneficial. While almost all 225 TEM-1 mutants (~99% in the DMS data set) and all natural variants ( Figure S3 and 226 Table S2 ) were deleterious at all ampicillin concentrations, kinetic data against 227 cefotaxime shows a substantially higher fraction of beneficial mutants (12 out of 16 228 mutants, Figure S4 ). From the figure, all ESBLs and TEM-1 mutants share the initial 229 rise in selection coefficient within the few hundred µg/ml of cefotaxime. Note that MIC of 230 cefotaxime is ~6 µM. The strongly beneficial nature of mutants in TEM-1 against 231 cefotaxime causes MSC to be ~1 µg/ml for all mutants. MPC is never reached within the 232 concentration range studied here, i.e., up to 10 6 µg/ml. As shown in Figure S5 , the 233 maximum s in cefotaxime dataset reaches is almost two orders of magnitude higher 234 than the selection coefficient of the most beneficial TEM-1 mutant against ampicillin. The knowledge of antimicrobial concentration at which resistance is prevented is crucial 239 for designing dosage strategies. As we showed in this work, and for the specific case of 240 TEM-1 beta lactamase against ampicillin and cefotaxime, a direct determination of MSC 241 and MPC is feasible if the fitness landscape of enzymes conferring antimicrobial 242 resistance, such as TEM-1 beta lactamase is known. As we showed in this work, both 243 MSC and MPC depend on catalytic efficiency of mutants, i.e., the V max /K M ratio in the 244 case of ampicillin. However, for strongly beneficial mutations, as observed in the case of 245 cefotaxime, MSC is essentially zero and MPC fall beyond the range of biologically 246 relevant concentrations. One would thus expect that resistance to cefotaxime is much 247 more prevalent than to ampicillin. Therefore, it is essential to estimate not only the 248 fraction of beneficial mutations but also the magnitude of fitness effects, i.e., the full 249 distribution of fitness effects (DFE). We thus propose that DFE obtained from deep 250 mutational scanning combined with fitness models, either biophysics-based as in this 251 work or phenomenological 33 , has a great potential to estimate the spectrum of 252
resistance. 253
In all calculations in this work, we assumed that both WT and mutants have 254 equal initial finesses. This assumption is biologically unrealistic as resistant mutants are 255
shown to be enriched in the population from very low fractions of the order of 10 -4 29 . To 256 check for this effect, we used the fraction of mutants in the population as a scaling 257 factor for fitness in Equation 2 (see Methods) and plotted selection coefficients versus 258 ampicillin for the case of I173H mutant in Figure 7B . From the figure, MSW is essentially 259 zero for the same beneficial mutation but with negligible fractions in the population. Therefore, figures 7B entails a window of opportunity for containment of AMR if 261 antibiotics are administered at the very onset of emergence of resistance. An exact 262 profiling of both type and fraction of resistant mutants is necessary for this purpose. 263
Two factors, namely bacterial population size and immune response, influence 264 the near-neutrality zone and potentially influence MSW and the fraction of beneficial 265 mutations. First, from classical population genetics, population size scales up fixation of 266 beneficial mutations. Since selection is stringer at higher population sizes, slightly 267 beneficial mutations at a smaller population (e.g., in the regime of N eff .s~1) could be 268 fixated with a higher rate at the larger population. Therefore, higher population sizes 269 decrease the width of near-neutrality zone and gives rise to lower MSC, higher MPC 270 and a wider MSW. 271
Second, in the absence of immune defense as in laboratory settings, the near-272 neutrality zone defines the lowest limit of selection. However, a major difference 273 between these settings and the clinical settings as in the patient body is the presence of 274 immune defense. In fact, the first response to bacterial infections is through the immune 275 system. Therefore, one expects that the real selection limit is extended above the near-276 neutrality zone and to the limit below which infection is contained by the immune 277 defense. This factor narrows down the MSW and thus the number of resistant 278 conferring mutations is further decreased. 279
We summarize the role of confounding factors on MSW as studied in this work in 280 Figure 7B . First, any factor that increases selective advantage of mutants such as a 281 higher catalytic efficiency widens MSW. We provided an equation for the relationship 282 between MSC and MPC to the V max /K M ratio and expect that such relationships exist for other antimicrobials and target enzymes. Second, MSW is substantially narrowed when 284 the fraction of resistant mutations is negligible in the population. Third, lower population 285 sizes or higher immune defense extend the near-neutrality zone and thus narrow down 286 MSW. We anticipate that optimization of MSW with respect to each of these factors 287 would provide a powerful strategy for rational design of dosage strategy in the treatment 288 of antimicrobial resistance. 289 290 291 292
Materials and method: 293 294
Fitness function 295
Determination of both upper and lower limits to MSW in our approach requires proper 296 definition of fitness of an organism. Following the original work of Zimmerman and 297 Rosselet 18 and the following theoretical works 17,34,35 , we assumed that beta lactam 298 antimicrobials passively diffuse through the outer membranes 36, 37 . Once in the 299 periplasm, the antimicrobial either get hydrolyzed by beta lactamase or diffuses to the 300 target PBP where competitively inhibits formation of peptidoglycan by interacting with 301 penicillin binding proteins ( Figure 1A) . The rate equations for beta lactam antibiotics and 302 peptidoglycan synthesis can be written as 303 
(Eq. 6) 305
As described earlier, the rate of beta lactam diffusion in the periplasm is assumed to be 306 equal to that of hydrolysis by beta lactamase 17,18 . Using fitness from Eq. 6, the relative 307 fitness ‫ܨ(‬ ) of each mutant to WT TEM-1 is then expressed as: 308
. 
453
Fitness is proportional to the rate of peptidoglycan formation and the activity of penicillin binding proteins.
454
Beta lactams involve in competitive inhibition of PBPs. The resulting fitness function is a function of I) 455 catalytic efficiency of beta lactamases, catalytic efficiency of PBPs, concentration of beta lactams in the 456 periplasm and cellular constants such a permeability of beta lactam antimicrobials. D) Using the 457 functionality of growth rate to different molecular and cellular constants, fitness of different mutants can 458 be expressed as a function of antimicrobial concentration. E) Selection coefficient of an arising mutation 459 can be expressed as a function of antimicrobial concentration depending on the fitness curves of WT and 460 resistant mutants. If mutant is more fit than WT (e.g., has a higher kinetic efficiency-the upper curve), 461 selection coefficient is positive, i.e., red arrow, otherwise negative, i.e., the blue arrow. 
507
A) S-curves of two TEM-1 mutants, G251R and L152C, which crosses at antimicrobial concentration of 508 ~4000 µg/ml. B) Ranks of TEM-1 mutants in selective advantage/disadvantage compared to the rank at 1 509 µg/ml as the reference set. C) Spearman correlation coefficients between the ranks at each concentration 510 below 1000 µg/ml and the reference at 1 µg/ml. 
